# Neostigmine and Dexamethasone in Adductor Canal Block

> **NCT04565301** · NA · COMPLETED · sponsor: **Cairo University** · enrollment: 90 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** neostigmine
- **OTHER:** NaCl solutions

## Key facts

- **NCT ID:** NCT04565301
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-20
- **Primary completion:** 2022-07-27
- **Final completion:** 2022-07-27
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2022-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04565301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04565301, "Neostigmine and Dexamethasone in Adductor Canal Block". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04565301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*